Boothbay Fund Management »

Eliem Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $632k 92k 6.85
2025-03-31 $66k 54k 1.22
2024-12-31 $97k 54k 1.80
2024-09-30 $273k 54k 5.09
2024-06-30 $218k 31k 7.11

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management
BlackRock

View all funds holding Eliem Therapeutics